Hua-Jay J Cherng

13PUBLICATIONS
97CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersAfrican languages
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 27, 2025
Cell-of-Origin Subtype Predicts Response to Polatuzumab Vedotin in Large B-cell Lymphoma.

Edward R Scheffer Cliff, Guido D Pelaez, Fei Wan

|Aug 13, 2025
Remission Assessment by Circulating Tumor DNA in Large B-Cell Lymphoma.

Mark Roschewski, David M Kurtz, Jason R Westin

|Nov 14, 2022
A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCL.

Hua-Jay J Cherng, Stefan K Alig, Yasuhiro Oki

Pageof 3